flâneur

MedTech looking to eliminate skin cancer fatalities raises £15m

businesscloud.co.uk · 508 words · saved by 1 readers

London-based Skin Analytics has seen its AI medical device detect over 14,000 cancers and will now look to expand internationally A MedTech company on a mission to build a future where nobody dies of skin cancer has secured £15m in Series B funding led by Intrepid Growth Partners. This investment follows Skin Analytics’ recent EU MDR Class III CE mark approval, making its technology, DERM, the world’s first legally authorised AI medical device to independently make clinical decisions on skin cancer without human review. The London-based firm will now use the funding to expand its focus and launch products that cover all dermatology concerns. It will also look to expand internationally in other key markets struggling with dermatologist shortages, such as Europe and Australia, and accelerate its move into the US market. The investment comes at a time of severe dermatologist shortages, with patients waiting months for potentially life-saving skin cancer checks. With an average of only abo

MedTech looking to eliminate skin cancer fatalities raises £15m Posted on April 16, 2025 by staff MedTech looking to eliminate skin cancer fatalities raises £15m London-based Skin Analytics has seen its AI medical device detect over 14,000 cancers and will now look to expand internationally Share: MedTech Investment A MedTech company on a mission to build a future where nobody dies of skin cancer has secured £15m in Series B funding led by Intrepid Growth Partners. This investment follows Skin Analytics’ recent EU MDR Class III CE mark approval, making its technology, DERM, the world’s first l

related reading